Genomics Meets Big Pharma: How Drug Companies are Betting on Pharmacogenomics
The advent of pharmacogenomics in drug development heralds a paradigm shift within the pharmaceutical sector. This evolution…
-
-
Pharmacogenomics in the Age of AI: Merging Genetics with Machine Learning for Tailored Treatments
As early as 2011, the potential of big data science in healthcare was foreseen as transformative for…
-
Pharmacogenomics and Rare Diseases: Bringing Hope to Orphan Drug Development
Rare diseases are a significant global health challenge, affecting millions worldwide. In the US, 30 million people,…
-
Advancements in Pharmacogenomic Testing: Implications for Drug Development
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National…
-
The Role of Pharmacogenomics in Addressing Racial and Ethnic Health Disparities
Despite the rapid evolution of genetic technologies, the integration of genomic insights to alleviate health disparities in…
-
Assessment of the Clinical Validity of Pharmacogenomics in Pain Management.
The Institute of Medicine reveals that one-third of the U.S. population grapples with persistent pain, underscoring a…
-
Lessons from COVID-19: Pharmacogenomics in Preparing for Future Pandemics
The COVID-19 pandemic has posed unprecedented challenges, prompting a critical inquiry: Might our genetic makeup hold the…
-
PGx-Guided Antiplatelet Therapy: Reducing Bleeding Risks with Personalized Dosing
Unlock personalized dosing for safer antiplatelet therapy with pharmacogenomics, reducing bleeding risks in cardiovascular care.
-
The Rise of Polygenic Risk Scores: Can PGx Predict Susceptibility to Medication Side Effects?
Explore how Polygenic Risk Scores enhance personalized medicine by predicting medication side effects and disease susceptibility.
-
The Lifeline of PGx and Factor V Leiden
Explore how PGx and Factor V Leiden intertwine to influence medication efficacy and safety for those with genetic clotting disorders.
-
Predict High Sensitivity to Warfarin Through CYP2C9
Discover how CYP2C9 genetic variations impact warfarin sensitivity and can guide personalized anticoagulant therapy for better patient outcomes.
